104 related articles for article (PubMed ID: 10797287)
1. Expression of E-cadherin reduces bcl-2 expression and increases sensitivity to etoposide-induced apoptosis.
Sasaki CY; Lin Hc; Passaniti A
Int J Cancer; 2000 Jun; 86(5):660-6. PubMed ID: 10797287
[TBL] [Abstract][Full Text] [Related]
2. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide.
Elliott MJ; Murphy KM; Stribinskiene L; Ranganathan V; Sturges E; Farnsworth ML; Lock RB
Cancer Chemother Pharmacol; 1999; 44(1):1-11. PubMed ID: 10367743
[TBL] [Abstract][Full Text] [Related]
4. Wild-type p53-dependent etoposide-induced apoptosis mediated by caspase-3 activation in human glioma cells.
Yin D; Tamaki N; Kokunai T
J Neurosurg; 2000 Aug; 93(2):289-97. PubMed ID: 10930016
[TBL] [Abstract][Full Text] [Related]
5. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
Fricke E; Hermannstädter C; Keller G; Fuchs M; Brunner I; Busch R; Höfler H; Becker KF; Luber B
Oncology; 2004; 66(2):150-9. PubMed ID: 15138368
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 expression correlates with apoptosis induction but not loss of clonogenic survival in small cell lung cancer cell lines treated with etoposide.
Breton C; Story MD; Meyn RE
Anticancer Drugs; 1998 Oct; 9(9):751-7. PubMed ID: 9840719
[TBL] [Abstract][Full Text] [Related]
7. High expression of endogenous bcl-2 and bcl-xL in thymic lymphomas do not diminish their sensitivity to etoposide-induced apoptosis.
Matuszyk J; Kalas W; Cebrat M; Strzadala L
Anticancer Res; 2001; 21(4A):2677-80. PubMed ID: 11724338
[TBL] [Abstract][Full Text] [Related]
8. Expression of alpha-catenin in alpha-catenin-deficient cells increases resistance to sphingosine-induced apoptosis.
Matsubara S; Ozawa M
J Cell Biol; 2001 Aug; 154(3):573-84. PubMed ID: 11489917
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors.
Taylor ST; Hickman JA; Dive C
J Natl Cancer Inst; 2000 Jan; 92(1):18-23. PubMed ID: 10620629
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
[TBL] [Abstract][Full Text] [Related]
11. Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells.
Rosso M; Lapyckyj L; Amiano N; Besso MJ; Sánchez M; Chuluyan E; Vazquez-Levin MH
Biol Cell; 2014 Sep; 106(9):308-22. PubMed ID: 25039920
[TBL] [Abstract][Full Text] [Related]
12. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells.
Kim R; Ohi Y; Inoue H; Toge T
Anticancer Res; 2000; 20(1A):439-44. PubMed ID: 10769693
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
Dole M; Nuñez G; Merchant AK; Maybaum J; Rode CK; Bloch CA; Castle VP
Cancer Res; 1994 Jun; 54(12):3253-9. PubMed ID: 8205548
[TBL] [Abstract][Full Text] [Related]
15. Truncated E-cadherin potentiates cell death in prostate epithelial cells.
Rios-Doria J; Day ML
Prostate; 2005 May; 63(3):259-68. PubMed ID: 15538719
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB
Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells.
Perkins C; Kim CN; Fang G; Bhalla KN
Cancer Res; 1998 Oct; 58(20):4561-6. PubMed ID: 9788601
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
Walczak H; Bouchon A; Stahl H; Krammer PH
Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
[TBL] [Abstract][Full Text] [Related]
20. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival.
Lock RB; Stribinskiene L
Cancer Res; 1996 Sep; 56(17):4006-12. PubMed ID: 8752171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
